
Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue


Vol 16
No 5
Sep/Oct 2025
Pain as the Fifth Vital Sign Challenges in Managing Cancer Related Pain
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
September 17, 2025
Women With Gynecologic Cancers: Screening for Substance Use Disorders Is Key
Lindsay Shor, DNP, WHNP-BC, Alison Edie, DNP, APRN, FNP-BC, Kathryn Trotter, DNP, CNM, FNP-BC, FAANP, FAAN Et al.
September 17, 2025
Tumor Treating Fields An Innovative Therapy for Glioblastoma and Other Solid Tumors
Jennifer N. Serventi, PA-C, Herbert B. Newton, MD
September 17, 2025